| SUN |
MON |
TUE |
WED |
THU |
FRI |
SAT |
| 1 |
2 |
3 |
4 |
5 |
6 |
7 |
| 8 |
9 |
10 |
11 |
12 |
13 |
14 |
| 15 |
16 |
17 |
18 |
19 |
20 |
21 |
| 22 |
23 |
24 |
25 |
26 |
27 |
28 |
| 29 |
30 |
|
|
|
|
|
■=seminar
dates
|
| 4 Apr. |
|
| 11 Apr. |
|
18 Apr.
|
Chairperson:
Suzu
Main Discusser Group: A
Koji Watanabe (Oka/Gatanaga Project Laboratory)
Crossclade CTL responses between clade B and CRF_01 A/E infected individuals in Japanese cohort
Teppei Toda(Immunology)
Molecular mechanism regarding the virus neutralization target of CD4 domain-3 in membrane fusion of Env-CD4-CXCR4 during HIV infection
|
25 Apr.
|
Chairperson:
Ueno
Main Discusser Group: B
Shinichiro Hattori (Okada Project Laboratory)
HIV-1 infection in a human NK cell-expanded NOJ mouse model
Salcedo G'omez Pedro Miguel (Hematology)
New prospective HIV-1 protease inhibitors: antiviral activity and pharmacological profiles |
|
